Award information
2025 Winner
Picture shows, left to right;
Nina Hossain, awards presenter; Alice Ingram, Manager, Accounting, Verona Pharma plc (award winner); Oliver Poulain, Director Finance, Verona Pharma plc (award winner); Victoria Stewart, Senior Director, Investor Relations & Communications, Verona Pharma plc (award winner); Simon Conway, Partner, FTI Consulting (award sponsor); Melody A. Carey, President & Chief Executive Officer, Rx Communications Group, LLC (Mainline sponsor); and Neil Shah, Executive Director, Content & Strategy, Edison Group (Mainline sponsor).
2025 Shortlist
- Adaptimmune Therapeutics plc
- Autolus Therapeutics plc
- Merus NV
- Newron Pharmaceuticals SpA
- Optima Health plc
- Verona Pharma plc
Criteria
The winner of this award will be the company or organisation which has achieved the most significant breakthrough during the period 1 April 2024 to 31 March 2025.
This breakthrough could be a new discovery, departure or breakthrough in technology, a significant positive change in its financial position, or other breakthrough which has added significantly to the company’s or organisation’s fortunes.